Does mild pulmonary stenosis progress during childhood? A study of its natural course

Julio Ardura1, Carmen Gonzalez, Jesus Andres

  • 1Pediatric Cardiology, University Hospital, Facultad de Medicina,Valladolid, Spain. ardura@ped.uva.es

Clinical Cardiology
|October 9, 2004
PubMed

Insights

Mild pulmonary stenosis in children with gradients below 40 mmHg is stable. These patients, aged over 6 months, do not require treatment and can be monitored every two years.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Physiology
  • Medical Diagnostics

Background:

  • Congenital pulmonary valvular stenosis (CPVS) management is debated, particularly regarding gradient changes during follow-up.
  • Determining the need for treatment in pediatric patients with CPVS is crucial.

Purpose of the Study:

  • To investigate the natural history of CPVS in pediatric patients.
  • To determine if a gradient below 50 mmHg at diagnosis indicates a stable or decreasing trend in CPVS.

Main Methods:

  • A 7-year follow-up study of 35 untreated pediatric patients with isolated pulmonary stenosis.
  • Utilized Doppler echocardiography and clinical formulas to measure pressure gradients.
  • Analyzed changes using statistical methods including Student's t-test and Pearson correlation.

Main Results:

  • No significant changes in clinical symptoms or physical examination findings were observed.
  • Cardiac enlargement decreased on ECG and chest X-ray (p<0.0001 and p<0.0007, respectively).
  • A statistically significant decreasing trend in pulmonary stenosis gradient was noted during follow-up (p<0.026).

Conclusions:

  • The observed gradient trend supports the stable nature of mild pulmonary stenosis.
  • Pediatric patients over 6 months with initial gradients <40 mmHg remained stable and did not require intervention.
  • Follow-up intervals for these patients can be extended to 2 years or more.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...